Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10342 in Previously Treated Advanced Breast Cancer
NCT05044988Phase 2Unknown
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of HS-10342 in breast cancer, sponsored by Hansoh Pharmaceutical Group. Status: unknown.
02
Drugs
HS-10342
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05044988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05044988.